Lung Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• Adults aged 18 or older.
• People who do not object to taking part in the study (and for those involved in the biological collection part of the study, a signed written consent form is required).
• People who have secondary bone tumours (cancer that has spread to the bones) originating from breast cancer, non-small cell lung cancer, kidney cancer, bladder cancer, thyroid cancer, or myeloma.
• People who have had, or will have as part of their usual care, a CT scan focused on the affected area taken within 30 days before or 20 days after joining the study.
• People whose affected bone is located in the upper part of the thigh bone (upper third of the femur) and/or in one or more vertebrae (bones of the spine). More than one location in the same person may be included, as long as each location meets the criteria.
• People whose affected area in the bone is either widespread through the bone or measures more than 15 mm in size.
• People who have been receiving certain bone-strengthening medications (such as clodronate, denosumab, zoledronic acid, or pamidronate) for 3 months or less are eligible.
• People who have previously received cancer treatments such as chemotherapy, targeted therapy, or immunotherapy are eligible.

Who may not be able to join:

• People who have already received treatment directed specifically at the target bone area, whether that was radiotherapy, surgery, or procedures such as cementoplasty, cryotherapy, or radiofrequency treatment.
• People whose target bone has already fractured.
• People being considered for the thigh bone (femur) target location who have a hip replacement on either side (the affected side or the other side).
• People who are under legal guardianship or trusteeship.

Important: Always verify eligibility with the trial site directly before applying.